{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:37:17Z","timestamp":1790487437062,"version":"4.1.0"},"reference-count":92,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1248\/bpb.b19-00088","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T22:08:36Z","timestamp":1577830116000},"page":"12-19","source":"Crossref","is-referenced-by-count":91,"title":["Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus"],"prefix":"10.1248","volume":"43","author":[{"given":"Masanori","family":"Fujii","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Division of Pathological Sciences, Kyoto Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol.<\/i>, 105<\/b>, 860\u2013876 (2000)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Elias PM, Steinhoff M. \u201cOutside-to-inside\u201d (and now back to \u201coutside\u201d) pathogenic mechanisms in atopic dermatitis. J. Invest. Dermatol.<\/i>, 128<\/b>, 1067\u20131070 (2008).","DOI":"10.1038\/jid.2008.88"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ. Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol.<\/i>, 129<\/b>, 1892\u20131908 (2009).","DOI":"10.1038\/jid.2009.133"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Koblenzer CS. Itching and the atopic skin. J. Allergy Clin. Immunol.<\/i>, 104<\/b>, S109\u2013S113 (1999).","DOI":"10.1016\/S0091-6749(99)70052-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J. Dermatol. Sci.<\/i>, 70<\/b>, 3\u201311 (2013).","DOI":"10.1016\/j.jdermsci.2013.02.001"},{"key":"6","unstructured":"6) Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al.<\/i> Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet.<\/i>, 38<\/b>, 441\u2013446 (2006)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mildner M, Jin J, Eckhart L, Kezic S, Gruber F, Barresi C, Stremnitzer C, Buchberger M, Mlitz V, Ballaun C, Sterniczky B, F\u00f6dinger D, Tschachler E. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J. Invest. Dermatol.<\/i>, 130<\/b>, 2286\u20132294 (2010).","DOI":"10.1038\/jid.2010.115"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) V\u00e1vrov\u00e1 K, Henkes D, Str\u00fcver K, Sochorov\u00e1 M, \u0160kolov\u00e1 B, Witting MY, Friess W, Schreml S, Meier RJ, Sch\u00e4fer-Korting M, Fluhr JW, K\u00fcchler S. Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct. J. Invest. Dermatol.<\/i>, 134<\/b>, 746\u2013753 (2014).","DOI":"10.1038\/jid.2013.402"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pendaries V, Malaisse J, Pellerin L, Le Lamer M, Nachat R, Kezic S, Schmitt AM, Paul C, Poumay Y, Serre G, Simon M. Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation. J. Invest. Dermatol.<\/i>, 134<\/b>, 2938\u20132946 (2014).","DOI":"10.1038\/jid.2014.259"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) van Drongelen V, Alloul-Ramdhani M, Danso MO, Mieremet A, Mulder A, van Smeden J, Bouwstra JA, El Ghalbzouri A. Knock-down of filaggrin does not affect lipid organization and composition in stratum corneum of reconstructed human skin equivalents. Exp. Dermatol.<\/i>, 22<\/b>, 807\u2013812 (2013).","DOI":"10.1111\/exd.12271"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kawasaki H, Nagao K, Kubo A, Hata T, Shimizu A, Mizuno H, Yamada T, Amagai M. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J. Allergy Clin. Immunol.<\/i>, 129<\/b>, 1538\u20131546.e6 (2012).","DOI":"10.1016\/j.jaci.2012.01.068"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Saunders SP, Moran T, Floudas A, Wurlod F, Kaszlikowska A, Salimi M, Quinn EM, Oliphant CJ, N\u00fa\u00f1ez G, McManus R, Hams E, Irvine AD, McKenzie AN, Ogg GS, Fallon PG. Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity. J. Allergy Clin. Immunol.<\/i>, 137<\/b>, 482\u2013491 (2016).","DOI":"10.1016\/j.jaci.2015.06.045"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Thyssen JP, Kezic S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol.<\/i>, 134<\/b>, 792\u2013799 (2014).","DOI":"10.1016\/j.jaci.2014.06.014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Jang H, Matsuda A, Jung K, Karasawa K, Matsuda K, Oida K, Ishizaka S, Ahn G, Amagai Y, Moon C, Kim SH, Arkwright PD, Takamori K, Matsuda H, Tanaka A. Skin pH is the master switch of kallikrein 5-mediated skin barrier destruction in a murine atopic dermatitis model. J. Invest. Dermatol.<\/i>, 136<\/b>, 127\u2013135 (2016).","DOI":"10.1038\/JID.2015.363"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Uchida Y, Holleran WM. Omega-O<\/i>-acylceramide, a lipid essential for mammalian survival. J. Dermatol. Sci.<\/i>, 51<\/b>, 77\u201387 (2008).","DOI":"10.1016\/j.jdermsci.2008.01.002"},{"key":"16","unstructured":"16) Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol.<\/i>, 96<\/b>, 523\u2013526 (1991)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yamamoto A, Serizawa S, Ito M, Sato Y. Stratum corneum lipid abnormalities in atopic dermatitis. Arch. Dermatol. Res.<\/i>, 283<\/b>, 219\u2013223 (1991).","DOI":"10.1007\/BF01106105"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm. Venereol.<\/i>, 78<\/b>, 27\u201330 (1998).","DOI":"10.1080\/00015559850135788"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ishikawa J, Narita H, Kondo N, Hotta M, Takagi Y, Masukawa Y, Kitahara T, Takema Y, Koyano S, Yamazaki S, Hatamochi A. Changes in the ceramide profile of atopic dermatitis patients. J. Invest. Dermatol.<\/i>, 130<\/b>, 2511\u20132514 (2010).","DOI":"10.1038\/jid.2010.161"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J. Invest. Dermatol.<\/i>, 119<\/b>, 166\u2013173 (2002).","DOI":"10.1046\/j.1523-1747.2002.01833.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Danso M, Boiten W, van Drongelen V, Gmelig Meijling K, Gooris G, El Ghalbzouri A, Absalah S, Vreeken R, Kezic S, van Smeden J, Lavrijsen S, Bouwstra J. Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition. J. Dermatol. Sci.<\/i>, 88<\/b>, 57\u201366 (2017).","DOI":"10.1016\/j.jdermsci.2017.05.005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mu\u00f1oz-Garcia A, Thomas CP, Keeney DS, Zheng Y, Brash AR. The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier. Biochim. Biophys. Acta<\/i>, 1841<\/b>, 401\u2013408 (2014).","DOI":"10.1016\/j.bbalip.2013.08.020"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Melton JL, Wertz PW, Swartzendruber DC, Downing DT. Effects of essential fatty acid deficiency on epidermal O<\/i>-acylsphingolipids and transepidermal water loss in young pigs. Biochim. Biophys. Acta<\/i>, 921<\/b>, 191\u2013197 (1987).","DOI":"10.1016\/0005-2760(87)90018-X"},{"key":"24","unstructured":"24) Murata Y, Ogata J, Higaki Y, Kawashima M, Yada Y, Higuchi K, Tsuchiya T, Kawainami S, Imokawa G. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J. Invest. Dermatol.<\/i>, 106<\/b>, 1242\u20131249 (1996)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Horrobin DF. Essential fatty acid metabolism and its modification in atopic eczema. Am. J. Clin. Nutr.<\/i>, 71<\/b> (Suppl.), 367S\u2013372S (2000).","DOI":"10.1093\/ajcn\/71.1.367s"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Jensen JM, F\u00f6lster-Holst R, Baranowsky A, Schunck M, Winoto-Morbach S, Neumann C, Sch\u00fctze S, Proksch E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J. Invest. Dermatol.<\/i>, 122<\/b>, 1423\u20131431 (2004).","DOI":"10.1111\/j.0022-202X.2004.22621.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K. S100 proteins in the epidermis. J. Invest. Dermatol.<\/i>, 123<\/b>, 23\u201333 (2004).","DOI":"10.1111\/j.0022-202X.2004.22719.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Abtin A, Eckhart L, Gl\u00e4ser R, Gmeiner R, Mildner M, Tschachler E. The antimicrobial heterodimer S100A8\/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes. J. Invest. Dermatol.<\/i>, 130<\/b>, 2423\u20132430 (2010).","DOI":"10.1038\/jid.2010.158"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, Cox HE, Coleman R, Leaves NI, Trembath RC, Moffatt MF, Harper JI. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat. Genet.<\/i>, 27<\/b>, 372\u2013373 (2001).","DOI":"10.1038\/86867"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Sugiura H, Ebise H, Tazawa T, Tanaka K, Sugiura Y, Uehara M, Kikuchi K, Kimura T. Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br. J. Dermatol.<\/i>, 152<\/b>, 146\u2013149 (2005).","DOI":"10.1111\/j.1365-2133.2005.06352.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Guttman-Yassky E, Su\u00e1rez-Fari\u00f1as M, Chiricozzi A, Nograles KE, Shemer A, Fuentes-Duculan J, Cardinale I, Lin P, Bergman R, Bowcock AM, Krueger JG. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J. Allergy Clin. Immunol.<\/i>, 124<\/b>, 1235\u20131244.e58 (2009).","DOI":"10.1016\/j.jaci.2009.09.031"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Su\u00e1rez-Fari\u00f1as M, Tintle SJ, Shemer A, Chiricozzi A, Nograles K, Cardinale I, Duan S, Bowcock AM, Krueger JG, Guttman-Yassky E. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J. Allergy Clin. Immunol.<\/i>, 127<\/b>, 954\u2013964.e4 (2011).","DOI":"10.1016\/j.jaci.2010.12.1124"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J. Allergy Clin. Immunol.<\/i>, 125<\/b>, 16\u201329.e11, 11, quiz, 30\u201331 (2010).","DOI":"10.1016\/j.jaci.2009.11.008"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Morar N, Cookson WO, Harper JI, Moffatt MF. Filaggrin mutations in children with severe atopic dermatitis. J. Invest. Dermatol.<\/i>, 127<\/b>, 1667\u20131672 (2007).","DOI":"10.1038\/sj.jid.5700739"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) De Benedetto A, Rafaels NM, McGirt LY, et al.<\/i> Tight junction defects in patients with atopic dermatitis. J. Allergy Clin. Immunol.<\/i>, 127<\/b>, 773\u2013786.e7 (2011).","DOI":"10.1016\/j.jaci.2010.10.018"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Tokumasu R, Yamaga K, Yamazaki Y, Murota H, Suzuki K, Tamura A, Bando K, Furuta Y, Katayama I, Tsukita S. Dose-dependent role of claudin-1 in vivo<\/i> in orchestrating features of atopic dermatitis. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 113<\/b>, E4061\u2013E4068 (2016).","DOI":"10.1073\/pnas.1525474113"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest.<\/i>, 101<\/b>, 1614\u20131622 (1998).","DOI":"10.1172\/JCI1647"},{"key":"38","unstructured":"38) Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J. Invest. Dermatol.<\/i>, 117<\/b>, 977\u2013983 (2001)."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Zheng T, Oh MH, Oh SY, Schroeder JT, Glick AB, Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J. Invest. Dermatol.<\/i>, 129<\/b>, 742\u2013751 (2009).","DOI":"10.1038\/jid.2008.295"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Trautmann A, Akdis M, Kleemann D, Altznauer F, Simon HU, Graeve T, Noll M, Br\u00f6cker EB, Blaser K, Akdis CA. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest.<\/i>, 106<\/b>, 25\u201335 (2000).","DOI":"10.1172\/JCI9199"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J. Invest. Dermatol.<\/i>, 105<\/b>, 749\u2013755 (1995).","DOI":"10.1111\/1523-1747.ep12325538"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J. Dermatol. Sci.<\/i>, 58<\/b>, 1\u20137 (2010).","DOI":"10.1016\/j.jdermsci.2010.02.008"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Bieber T. Atopic dermatitis. N. Engl. J. Med.<\/i>, 358<\/b>, 1483\u20131494 (2008).","DOI":"10.1056\/NEJMra074081"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Yoshida K, Kubo A, Fujita H, Yokouchi M, Ishii K, Kawasaki H, Nomura T, Shimizu H, Kouyama K, Ebihara T, Nagao K, Amagai M. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J. Allergy Clin. Immunol.<\/i>, 134<\/b>, 856\u2013864 (2014).","DOI":"10.1016\/j.jaci.2014.08.001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol.<\/i>, 3<\/b>, 673\u2013680 (2002).","DOI":"10.1038\/ni805"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Comeau MR, Campbell DJ, Ziegler SF. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med.<\/i>, 202<\/b>, 541\u2013549 (2005).","DOI":"10.1084\/jem.20041503"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Elentner A, Finke D, Schmuth M, Chappaz S, Ebner S, Malissen B, Kissenpfennig A, Romani N, Dubrac S. Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J. Cell. Mol. Med.<\/i>, 13<\/b> (8B), 2658\u20132672 (2009).","DOI":"10.1111\/j.1582-4934.2009.00797.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Nakajima S, Igy\u00e1rt\u00f3 BZ, Honda T, Egawa G, Otsuka A, Hara-Chikuma M, Watanabe N, Ziegler SF, Tomura M, Inaba K, Miyachi Y, Kaplan DH, Kabashima K. Langerhans cells are critical in epicutaneous sensitization with protein antigen via<\/i> thymic stromal lymphopoietin receptor signaling. J. Allergy Clin. Immunol.<\/i>, 129<\/b>, 1048\u20131055.e6 (2012).","DOI":"10.1016\/j.jaci.2012.01.063"},{"key":"49","unstructured":"49) Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtim\u00e4ki S, Karisola P, Reunala T, Wolff H, Lauerma A, Alenius H. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J. Invest. Dermatol.<\/i>, 132<\/b>, 1392\u20131400 (2012)."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T, Nakanishi K, Yamanishi K. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 110<\/b>, 13921\u201313926 (2013).","DOI":"10.1073\/pnas.1307321110"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, Huang LC, Johnson D, Scanlon ST, McKenzie AN, Fallon PG, Ogg GS. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med.<\/i>, 210<\/b>, 2939\u20132950 (2013).","DOI":"10.1084\/jem.20130351"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J. Clin. Invest.<\/i>, 99<\/b>, 3009\u20133017 (1997).","DOI":"10.1172\/JCI119496"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Pastore S, Corinti S, La Placa M, Didona B, Girolomoni G. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J. Allergy Clin. Immunol.<\/i>, 101<\/b>, 538\u2013544 (1998).","DOI":"10.1016\/S0091-6749(98)70361-6"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol.<\/i>, 171<\/b>, 3262\u20133269 (2003).","DOI":"10.4049\/jimmunol.171.6.3262"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Ikoma A, Steinhoff M, St\u00e4nder S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat. Rev. Neurosci.<\/i>, 7<\/b>, 535\u2013547 (2006).","DOI":"10.1038\/nrn1950"},{"key":"56","unstructured":"56) St\u00e4nder S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp. Dermatol.<\/i>, 11<\/b>, 12\u201324 (2002)."},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Wahlgren CF, H\u00e4germark O, Bergstr\u00f6m R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br. J. Dermatol.<\/i>, 122<\/b>, 545\u2013551 (1990).","DOI":"10.1111\/j.1365-2133.1990.tb14732.x"},{"key":"58","unstructured":"58) Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J. Allergy Clin. Immunol.<\/i>, 117<\/b>, 411\u2013417 (2006)."},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Dillon SR, Sprecher C, Hammond A, et al.<\/i> Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol.<\/i>, 5<\/b>, 752\u2013760 (2004).","DOI":"10.1038\/ni1084"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Arai I, Tsuji M, Takeda H, Akiyama N, Saito S. A single dose of interleukin-31 (IL-31) causes continuous itch-associated scratching behaviour in mice. Exp. Dermatol.<\/i>, 22<\/b>, 669\u2013671 (2013).","DOI":"10.1111\/exd.12222"},{"key":"61","unstructured":"61) Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, Kukova G, Buhl T, Ikoma A, Buddenkotte J, Soumelis V, Feld M, Alenius H, Dillon SR, Carstens E, Homey B, Basbaum A, Steinhoff M. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J. Allergy Clin. Immunol.<\/i>, 133<\/b>, 448\u2013460 (2014)."},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Hawro T, Saluja R, Weller K, Altrichter S, Metz M, Maurer M. Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge. Allergy<\/i>, 69<\/b>, 113\u2013117 (2014).","DOI":"10.1111\/all.12316"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Ruzicka T, Hanifin JM, Furue M, Pulka G, Mlynarczyk I, Wollenberg A, Galus R, Etoh T, Mihara R, Yoshida H, Stewart J, Kabashima K. Anti-interleukin-31 receptor A antibody for atopic dermatitis. N. Engl. J. Med.<\/i>, 376<\/b>, 826\u2013835 (2017).","DOI":"10.1056\/NEJMoa1606490"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Wilson SR, Th\u00e9 L, Batia LM, Beattie K, Katibah GE, McClain SP, Pellegrino M, Estandian DM, Bautista DM. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell<\/i>, 155<\/b>, 285\u2013295 (2013).","DOI":"10.1016\/j.cell.2013.08.057"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J. Exp. Med.<\/i>, 206<\/b>, 1135\u20131147 (2009).","DOI":"10.1084\/jem.20082242"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Oetjen LK, Mack MR, Feng J, et al.<\/i> Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch. Cell<\/i>, 171<\/b>, 217\u2013228.e13 (2017).","DOI":"10.1016\/j.cell.2017.08.006"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Beck LA, Tha\u00e7i D, Hamilton JD, Graham NM, Bieber T, Rocklin R, Ming JE, Ren H, Kao R, Simpson E, Ardeleanu M, Weinstein SP, Pirozzi G, Guttman-Yassky E, Su\u00e1rez-Fari\u00f1as M, Hager MD, Stahl N, Yancopoulos GD, Radin AR. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N. Engl. J. Med.<\/i>, 371<\/b>, 130\u2013139 (2014).","DOI":"10.1056\/NEJMoa1314768"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Tobin D, Nabarro G, Baart de la Faille H, van Vloten WA, van der Putte SC, Schuurman HJ. Increased number of immunoreactive nerve fibers in atopic dermatitis. J. Allergy Clin. Immunol.<\/i>, 90<\/b>, 613\u2013622 (1992).","DOI":"10.1016\/0091-6749(92)90134-N"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch. Dermatol. Res.<\/i>, 289<\/b>, 125\u2013131 (1997).","DOI":"10.1007\/s004030050167"},{"key":"70","unstructured":"70) Tominaga M, Takamori K. Sensitization of itch signaling: itch sensitization\u2013nerve growth factor, semaphorins. Itch: Mechanisms and Treatment<\/i>. (Carstens E, Akiyama T, eds.) Chapter 17. Frontiers in Neuroscience, CRC Press\/Taylor & Francis, Boca Raton, FL (2014)."},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Murota H, Izumi M, Abd El-Latif MI, Nishioka M, Terao M, Tani M, Matsui S, Sano S, Katayama I. Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis. J. Allergy Clin. Immunol.<\/i>, 130<\/b>, 671\u2013682.e4 (2012).","DOI":"10.1016\/j.jaci.2012.05.027"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G, Hevezi P, Plesser K, Schrumpf H, Krjutskov K, Sergeeva O, M\u00fcller HW, Tsoka S, Kere J, Dillon SR, Steinhoff M, Homey B. The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J. Allergy Clin. Immunol.<\/i>, 138<\/b>, 500\u2013508.e4 (2016).","DOI":"10.1016\/j.jaci.2016.02.020"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Rukwied RR, Main M, Weinkauf B, Schmelz M. NGF sensitizes nociceptors for cowhage- but not histamine-induced itch in human skin. J. Invest. Dermatol.<\/i>, 133<\/b>, 268\u2013270 (2013).","DOI":"10.1038\/jid.2012.242"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Mochizuki H, Schut C, Nattkemper LA, Yosipovitch G. Brain mechanism of itch in atopic dermatitis and its possible alteration through non-invasive treatments. Allergol. Int.<\/i>, 66<\/b>, 14\u201321 (2017).","DOI":"10.1016\/j.alit.2016.08.013"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Schut C, Mochizuki H, Grossman SK, Lin AC, Conklin CJ, Mohamed FB, Gieler U, Kupfer J, Yosipovitch G. Brain processing of contagious itch in patients with atopic dermatitis. Front. Psychol.<\/i>, 8<\/b>, 1267 (2017).","DOI":"10.3389\/fpsyg.2017.01267"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Fujii M, Nakamura T, Fukuno S, Mizutani N, Nabe T, Kohno S. Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitis. Eur. J. Pharmacol.<\/i>, 611<\/b>, 92\u201399 (2009).","DOI":"10.1016\/j.ejphar.2009.03.051"},{"key":"77","unstructured":"77) Fujii M, Takeuchi K, Umehara Y, Takeuchi M, Nakayama T, Ohgami S, Asano E, Nabe T, Ohya S. Barbiturates enhance itch-associated scratching in atopic dermatitis mice: A possible clue to understanding nocturnal pruritus in atopic dermatitis. Eur. J. Pharmacol.<\/i>, 836<\/b>, 57\u201366 (2018)."},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Fujii M, Ohgami S, Asano E, Nakayama T, Toda T, Nabe T, Ohya S. Brain allopregnanolone induces marked scratching behaviour in diet-induced atopic dermatitis mouse model. Sci. Rep.<\/i>, 9<\/b>, 2364 (2019).","DOI":"10.1038\/s41598-019-38858-3"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Ebata T, Aizawa H, Kamide R, Niimura M. The characteristics of nocturnal scratching in adults with atopic dermatitis. Br. J. Dermatol.<\/i>, 141<\/b>, 82\u201386 (1999).","DOI":"10.1046\/j.1365-2133.1999.02924.x"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur. J. Immunol.<\/i>, 28<\/b>, 769\u2013779 (1998).","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Onoue A, Kabashima K, Kobayashi M, Mori T, Tokura Y. Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin. Exp. Dermatol.<\/i>, 18<\/b>, 1036\u20131043 (2009).","DOI":"10.1111\/j.1600-0625.2009.00899.x"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest.<\/i>, 122<\/b>, 440\u2013447 (2012).","DOI":"10.1172\/JCI57416"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY. Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol.<\/i>, 120<\/b>, 150\u2013155 (2007).","DOI":"10.1016\/j.jaci.2007.04.031"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Seltmann J, Roesner LM, von Hesler FW, Wittmann M, Werfel T. IL-33 impacts on the skin barrier by downregulating the expression of filaggrin. J. Allergy Clin. Immunol.<\/i>, 135<\/b>, 1659\u20131661.e4 (2015).","DOI":"10.1016\/j.jaci.2015.01.048"},{"key":"85","unstructured":"85) Sawada E, Yoshida N, Sugiura A, Imokawa G. Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis. J. Dermatol. Sci.<\/i>, 68<\/b>, 25\u201335 (2012)."},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin. Immunol.<\/i>, 126<\/b>, 332\u2013337 (2008).","DOI":"10.1016\/j.clim.2007.11.006"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Tominaga M, Ozawa S, Tengara S, Ogawa H, Takamori K. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. J. Dermatol. Sci.<\/i>, 48<\/b>, 103\u2013111 (2007).","DOI":"10.1016\/j.jdermsci.2007.06.003"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J. Allergy Clin. Immunol.<\/i>, 126<\/b>, 976\u2013984.e5 (2010).","DOI":"10.1016\/j.jaci.2010.08.041"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Cornelissen C, Marquardt Y, Czaja K, Wenzel J, Frank J, L\u00fcscher-Firzlaff J, L\u00fcscher B, Baron JM. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J. Allergy Clin. Immunol.<\/i>, 129<\/b>, 426\u2013433.e8 (2012).","DOI":"10.1016\/j.jaci.2011.10.042"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Singh B, Jegga AG, Shanmukhappa KS, Edukulla R, Khurana Hershey GH, Medvedovic M, Dillon SR, Madala SK. IL-31-Driven skin remodeling involves epidermal cell proliferation and thickening that lead to impaired skin\u2013barrier function. PLOS ONE<\/i>, 11<\/b>, e0161877 (2016).","DOI":"10.1371\/journal.pone.0161877"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91) Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol.<\/i>, 30<\/b>, 535\u2013546 (1994).","DOI":"10.1016\/S0190-9622(94)70059-1"},{"key":"92","unstructured":"92) Paller AS, Kabashima K, Bieber T. Therapeutic pipeline for atopic dermatitis: end of the drought? J. Allergy Clin. Immunol.<\/i>, 140<\/b>, 633\u2013643 (2017)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/1\/43_b19-00088\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T17:38:53Z","timestamp":1613324333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/1\/43_b19-00088\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00088","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}